Amplia Therapeutics (ASX:ATX) plans to expand its US presence, including via a filing to uplist from the Pink Sheet to the OTCQB exchange, according to a Friday Australian bourse filing.
The firm is embarking on an expanded capital markets campaign, which includes activities with several financial institutions.
The firm's shares jumped 5% in recent trading on the Australian bourse on Friday.